Factor IX Inhibitors in Hemophilia B

Jeanne M. Lusher, Meera Chitlur

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations
Original languageEnglish
Title of host publicationTextbook of Hemophilia
Subtitle of host publicationSecond Edition
Number of pages3
ISBN (Print)9781405169141
StatePublished - Aug 13 2010


  • Bleeding episode management in patients with factor IX inhibitors
  • FEIBA-VH, effective in bleeding situations
  • Factor (F) IX inhibitors, uncommon in 3% of persons with hemophilia B
  • Factor IX inhibitors in hemophilia B
  • Hemophilia patient B management - complications by factor IX inhibitor
  • Immune tolerance induction (ITI) regimen
  • Mutations in FIX gene - increased incidence of inhibitor development
  • Patients with inhibitor to FIX and anaphylaxis history to FIX - treatment with rFVIIa
  • Scientific and Standardization Committee (SSC)


Dive into the research topics of 'Factor IX Inhibitors in Hemophilia B'. Together they form a unique fingerprint.

Cite this